Annals of Oncology Advance Access originally published online on January 21, 2008
Annals of Oncology 2008 19(5):903-908; doi:10.1093/annonc/mdm552
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gastrointestinal tumors |
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
1 Department of Surgical and Gastroenterological Sciences
2 Department of Medicine and Public Health
3 Department of Pathology, University of Verona, Verona
4 Department of Digestive and Liver Disease, II School of Medicine, University ‘La Sapienza’, Rome, Italy
* Correspondence to: Dr M. Falconi, Chirurgia Generale B, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Policlinico ‘GB Rossi’, P.le LA Scuro 10, 37134 Verona, Italy. Tel: +39-045-8124553; Fax: +39-045-8201294; E-mail: massimo.falconi{at}univr.it
Background: Non-functioning pancreatic endocrine tumours (NF-PETs) are an aggressive gastroenteropancreatic neoplasm. The present study assessed survival, value of World Health Organisation (WHO) classification and prognostic utility of clinicopathological parameters at diagnosis.
Patients and methods: From 1990 to 2004, 180 patients with NF-PETs were entered in a prospective database, and predictors of prognosis were tested in uni- and multivariate models.
Results: There were 25 (14%) benign lesions, 38 (21%) neoplasms of uncertain behaviour, 100 well-differentiated carcinomas (56%) and 17 poorly differentiated carcinomas (9%). Radical resection was possible in 93 cases (51.6%). Overall 5-, 10- and 15-year survival rates were 67%, 49.3% and 32.8%, respectively, and were significantly higher in radically resected patients (93%, 80.8% and 65.2%, respectively; P < 0.00001). By multivariate analysis, poor differentiation [hazard ratio (HR) 7.3; P = 0.0001], nodal metastases (HR 3.05; P = 0.02), liver metastases (HR 3.29; P = 0.003), Ki-67 >5% (HR 2.5; P = 0.012) and weight loss (HR 3.06; P = 0.001) were significantly associated with mortality.
Conclusion: This study confirms the good long-term survival of patients with NF-PETs and the prognostic value of WHO classification, liver metastases, poor differentiation, Ki-67, nodal metastases and weight loss. These latter two parameters have a prognostic value similar to that of liver metastases and Ki-67.
Key words: pancreatic endocrine tumours, pancreatic neoplasm, pancreatic surgery, prognostic factors, survival
Received for publication August 27, 2007. Revision received November 2, 2007. Accepted for publication November 5, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Missiaglia, I. Dalai, S. Barbi, S. Beghelli, M. Falconi, M. della Peruta, L. Piemonti, G. Capurso, A. Di Florio, G. delle Fave, et al. Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway J. Clin. Oncol., January 10, 2010; 28(2): 245 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Iwasa, C. Morizane, T. Okusaka, H. Ueno, M. Ikeda, S. Kondo, T. Tanaka, K. Nakachi, S. Mitsunaga, Y. Kojima, et al. Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas Jpn. J. Clin. Oncol., January 4, 2010; (2010) hyp173v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Durante, H. Boukheris, C. Dromain, P. Duvillard, S. Leboulleux, D. Elias, T. de Baere, D. Malka, J. Lumbroso, J. Guigay, et al. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma Endocr. Relat. Cancer, June 1, 2009; 16(2): 585 - 597. [Abstract] [Full Text] [PDF]
|
|